Apo-Gabapentin New Zealand - English - Medsafe (Medicines Safety Authority)

apo-gabapentin

apotex nz ltd - gabapentin 800mg;   - film coated tablet - 800 mg - active: gabapentin 800mg   excipient: copovidone hyprolose hypromellose macrogol 8000 magnesium stearate titanium dioxide - gabapentin is indicated for the treatment of neuropathic pain in adults over 18 years of age

APO-GABAPENTIN gabapentin 800mg tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-gabapentin gabapentin 800mg tablets bottle

arrotex pharmaceuticals pty ltd - gabapentin, quantity: 800 mg - tablet, film coated - excipient ingredients: copovidone; magnesium stearate; titanium dioxide; macrogol 8000; hypromellose; hyprolose - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.

Prezista New Zealand - English - Medsafe (Medicines Safety Authority)

prezista

janssen-cilag (new zealand) ltd - darunavir ethanolate 867.28mg equivalent to darunavir 800 mg - film coated tablet - 800 mg - active: darunavir ethanolate 867.28mg equivalent to darunavir 800 mg excipient: colloidal silicon dioxide crospovidone hypromellose magnesium stearate opadry red 85f150004 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

PREZISTA darunavir 800 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

prezista darunavir 800 mg tablet bottle

janssen-cilag pty ltd - darunavir, quantity: 800 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - adult patients,prezista ( with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents, for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.,paediatric patients,prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in treatment-experienced paediatric patients aged 6 years and older, weighing at least 20 kg.

Neurontin New Zealand - English - Medsafe (Medicines Safety Authority)

neurontin

pharmacy retailing (nz) ltd t/a healthcare logistics - gabapentin 800mg; gabapentin 800mg - film coated tablet - 800 mg - active: gabapentin 800mg excipient: candelilla wax crospovidone magnesium stearate maize starch nitrogen opacode orange ns-78-13026 opadry white ys-1-18111 poloxamer 407 purified water active: gabapentin 800mg excipient: candelilla wax crospovidone magnesium stearate maize starch nitrogen opadry white ys-1-18111 poloxamer 407 purified water - neurontin is indicated for the treatment of partial seizures with or without secondarily generalised tonic-clonic seizures, in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs

Renagel New Zealand - English - Medsafe (Medicines Safety Authority)

renagel

pharmacy retailing (nz) ltd t/a healthcare logistics - sevelamer hydrochloride 800mg;   - film coated tablet - 800 mg - active: sevelamer hydrochloride 800mg   excipient: colloidal silicon dioxide purified water stearic acid

RENAGEL sevelamer hydrochloride 800 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

renagel sevelamer hydrochloride 800 mg tablet bottle

sanofi-aventis australia pty ltd - sevelamer hydrochloride, quantity: 800 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; stearic acid; hypromellose; acetylated monoglycerides; propylene glycol; isopropyl alcohol; purified water; iron oxide black - renagel is indicated for the management of hyperphosphataemia in adult patients with stage 4 and 5 chronic kidney disease.

Zovirax New Zealand - English - Medsafe (Medicines Safety Authority)

zovirax

glaxosmithkline nz limited - aciclovir 800mg - dispersible tablet - 800 mg - active: aciclovir 800mg excipient: aluminium magnesium silicate hypromellose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - zovirax dispersible tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. zovirax dispersible tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. zovirax dispersible tablets are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.